ID16929A - ANTI VAGINITICAL COMPOSITION FOR TOPICAL USE. - Google Patents

ANTI VAGINITICAL COMPOSITION FOR TOPICAL USE.

Info

Publication number
ID16929A
ID16929A IDP971652A ID971652A ID16929A ID 16929 A ID16929 A ID 16929A ID P971652 A IDP971652 A ID P971652A ID 971652 A ID971652 A ID 971652A ID 16929 A ID16929 A ID 16929A
Authority
ID
Indonesia
Prior art keywords
vaginitical
composition
topical use
topical
vaginitical composition
Prior art date
Application number
IDP971652A
Other languages
Indonesian (id)
Inventor
Koral Embil
Oswald Morton
Original Assignee
Edko Trading Representation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10793879&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID16929(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Edko Trading Representation filed Critical Edko Trading Representation
Publication of ID16929A publication Critical patent/ID16929A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gynecology & Obstetrics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IDP971652A 1996-05-17 1997-05-19 ANTI VAGINITICAL COMPOSITION FOR TOPICAL USE. ID16929A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9610359.3A GB9610359D0 (en) 1996-05-17 1996-05-17 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ID16929A true ID16929A (en) 1997-11-20

Family

ID=10793879

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP971652A ID16929A (en) 1996-05-17 1997-05-19 ANTI VAGINITICAL COMPOSITION FOR TOPICAL USE.

Country Status (12)

Country Link
EP (1) EP0910377A1 (en)
JP (1) JP2000513334A (en)
CN (1) CN1127338C (en)
AU (1) AU2905597A (en)
BR (1) BR9709316A (en)
GB (1) GB9610359D0 (en)
ID (1) ID16929A (en)
MY (1) MY127711A (en)
RU (1) RU2195281C2 (en)
TR (1) TR199802351T2 (en)
WO (1) WO1997044032A1 (en)
ZA (1) ZA974266B (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2777783A1 (en) * 1998-04-24 1999-10-29 Innothera Lab Sa Pharmaceutical composition for treatment of infectious vulvovaginitis and vaginosis
US5993836A (en) * 1998-04-28 1999-11-30 Castillo; James G. Topical anesthetic formulation
TWI232111B (en) * 1999-08-06 2005-05-11 Upjohn Co Intravaginal clindamycin ovule composition
US20030114394A1 (en) * 2001-10-29 2003-06-19 Levine Howard L. Vaginally administered anti-dysrhythmic agents for treating pelvic pain
US8425892B2 (en) 2001-10-29 2013-04-23 Columbia Laboratories, Inc. Extended, controlled-release pharmaceutical compositions using charged polymers
AU2004274000B2 (en) 2003-09-19 2009-07-30 Drugtech Corporation Pharmaceutical delivery system
US8309103B2 (en) * 2004-01-22 2012-11-13 Alparis, S.A. De C.V. Association of fluconazole-tinidazole for the treatment of vaginal infections, its composition, preparation process and usage
GB0405406D0 (en) * 2004-03-10 2004-04-21 Edko Pazarlama Tanitim Ltd Sti Anti-vaginitis compositions
CN101170993A (en) * 2005-05-09 2008-04-30 药物技术公司 Modified-release pharmaceutical compositions
CN1291754C (en) * 2005-07-12 2006-12-27 李赴朝 Localized anesthesia synergistic delay agent
KR20080083190A (en) * 2006-01-05 2008-09-16 드러그테크 코포레이션 Drug delivery system for bioadhesion to a vulvovaginal surface
CN101374501A (en) * 2006-01-05 2009-02-25 药物技术公司 Composition and method of use thereof
RU2605343C1 (en) * 2015-11-30 2016-12-20 Государственное бюджетное образовательное учреждение высшего профессионального образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации Agent for treating pyoinflammatory processes in soft tissues and mucous membranes
RU2603490C1 (en) * 2015-11-30 2016-11-27 Государственное бюджетное образовательное учреждение высшего профессионального образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации Agent for treating pyoinflammatory processes in soft tissues and mucous membranes
BR112018077430A2 (en) 2016-07-08 2019-04-02 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A pharmaceutical composition.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8830405D0 (en) * 1988-12-30 1989-03-01 Embil Koral Pharmaceutical formulation

Also Published As

Publication number Publication date
GB9610359D0 (en) 1996-07-24
WO1997044032A1 (en) 1997-11-27
JP2000513334A (en) 2000-10-10
MY127711A (en) 2006-12-29
CN1127338C (en) 2003-11-12
ZA974266B (en) 1998-11-16
BR9709316A (en) 2000-05-02
AU2905597A (en) 1997-12-09
TR199802351T2 (en) 1999-03-22
CN1223581A (en) 1999-07-21
EP0910377A1 (en) 1999-04-28
RU2195281C2 (en) 2002-12-27

Similar Documents

Publication Publication Date Title
TR199501406A2 (en) Wrinkle removal composition.
BR9707786B1 (en) compound.
NO20052407D0 (en) Barberhovelhandtak.
BR9706717B1 (en) distribution mechanism.
DE69718508T2 (en) ANTITRASPIRANT COMPOSITION
DE69721231D1 (en) ANISOTROP LEADING COMPOSITION
ID18359A (en) MICROCAPSUL COMPOSITION
ID16929A (en) ANTI VAGINITICAL COMPOSITION FOR TOPICAL USE.
ID19589A (en) COMPOSITION
TR199700762A3 (en) Damage aerosol composition.
FR2748659B1 (en) TOPICAL SLIMMING COMPOSITION
ITTO970975A0 (en) ORGANIC COMPOSITIONS.
BR9707835A (en) Composition
BR9709815A (en) Composition
DE69709173T2 (en) BELASTUNGSWALZENANORDNÜNG.
NL1007050A1 (en) Truck.
NO991735D0 (en) The composition
ES1035709Y (en) BLOCK FOR CONSTRUCTION.
SE9602664D0 (en) Topical composition
ES1033200Y (en) FLASHLIGHT - CANDY.
ES1028579Y (en) DRAIN FOR RAINWATER.
ID17791A (en) NONAFLUOROMETOKSIBUTANA COMPOSITION
ES1033500Y (en) BOX-EXHIBITOR.
ES1035219Y (en) PIN-CLIP.
ES1034158Y (en) ARSONVALIZER.